Ki Summary

Reaction Details

Report a problem with these data

Target

Serine/threonine-protein kinase Chk1

Ligand

BDBM50245575

Substrate/Competitor

n/a

Meas. Tech.

ChEMBL_511069 (CHEMBL1000361)

IC50

850±n/a nM

Citation

Smaill, JB; Baker, EN; Booth, RJ; Bridges, AJ; Dickson, JM; Dobrusin, EM; Ivanovic, I; Kraker, AJ; Lee, HH; Lunney, EA; Ortwine, DF; Palmer, BD; Quin, J; Squire, CJ; Thompson, AM; Denny, WA Synthesis and structure-activity relationships of N-6 substituted analogues of 9-hydroxy-4-phenylpyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as inhibitors of Wee1 and Chk1 checkpoint kinases. Eur J Med Chem43:1276-96 (2008) [PubMed] Article

More Info.:

Get all data from this article, Assay Method

Serine/threonine-protein kinase Chk1

Name:

Serine/threonine-protein kinase Chk1

Synonyms:

CHEK1 | CHK1 | CHK1 checkpoint homolog | CHK1_HUMAN | Checkpoint kinase-1 (CHK1)

Type:

Enzyme Catalytic Domain

Mol. Mass.:

54443.02

Organism:

Homo sapiens (Human)

Description:

gi_166295192

Residue:

476

Sequence:

MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK
MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY
LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK
RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA
LLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDF
SPVNSASSEENVKYSSSQPEPRTGLSLWDTSPSYIDKLVQGISFSQPTCPDHMLLNSQLL
GTPGSSQNPWQRLVKRMTRFFTKLDADKSYQCLKETCEKLGYQWKKSCMNQVTISTTDRR
NNKLIFKVNLLEMDDKILVDFRLSKGDGLEFKRHFLKIKGKLIDIVSSQKIWLPAT

BDBM50245575

n/a

Name

BDBM50245575

Synonyms:

4-(2,6-dichlorophenyl)-6-(2-(dimethylamino)ethyl)-9-hydroxypyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione | CHEMBL487031

Type

Small organic molecule

Emp. Form.

C24H19Cl2N3O3

Mol. Mass.

468.332

SMILES

CN(C)CCn1c2ccc(O)cc2c2c3C(=O)NC(=O)c3c(cc12)-c1c(Cl)cccc1Cl |(24.43,-31.38,;22.93,-31.06,;21.9,-32.21,;22.45,-29.6,;23.48,-28.45,;23,-26.99,;21.52,-26.51,;20.19,-27.28,;18.86,-26.51,;18.86,-24.97,;17.52,-24.2,;20.19,-24.2,;21.52,-24.96,;23,-24.48,;23.63,-23.07,;23,-21.67,;21.5,-21.34,;24.15,-20.64,;25.48,-21.41,;26.88,-20.79,;25.15,-22.91,;26.08,-24.17,;25.44,-25.58,;23.9,-25.74,;27.6,-24.01,;28.5,-25.26,;27.88,-26.66,;30.03,-25.1,;30.66,-23.69,;29.75,-22.44,;28.22,-22.61,;28.21,-21.06,)|

Structure